These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25874914)

  • 1. Transient agranulocytosis associated with ziprasidone in a 45-year-old man on hemodialysis.
    Iskandar JW; Vance JE; Kablinger A; Kavuru B
    J Clin Psychopharmacol; 2015 Jun; 35(3):347-8. PubMed ID: 25874914
    [No Abstract]   [Full Text] [Related]  

  • 2. Ziprasidone-related agranulocytosis following olanzapine-induced neutropenia.
    Montgomery J
    Gen Hosp Psychiatry; 2006; 28(1):83-5. PubMed ID: 16377373
    [No Abstract]   [Full Text] [Related]  

  • 3. A case report with ziprasidone-induced catatonic symptoms.
    Markham-Abedi C; McNeely C; de Leon J
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):476-7. PubMed ID: 18070860
    [No Abstract]   [Full Text] [Related]  

  • 4. Ziprasidone-associated pedal edema in the treatment of schizophrenia.
    Ku HL; Su TP; Chou YH
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):963-4. PubMed ID: 16624468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ziprasidone approved.
    Hirsch M
    Harv Ment Health Lett; 2001 Jun; 17(12):8. PubMed ID: 11439926
    [No Abstract]   [Full Text] [Related]  

  • 6. Possible ziprasidone-induced mania.
    Larson MF; Hauser A
    J Am Acad Child Adolesc Psychiatry; 2003 Sep; 42(9):1012; discussion 1012-3. PubMed ID: 12964565
    [No Abstract]   [Full Text] [Related]  

  • 7. Introduction. Ziprasidone in schizophrenia: from acute treatment to long-term management.
    Kane JM
    J Clin Psychiatry; 2003; 64 Suppl 19():3-5. PubMed ID: 14728083
    [No Abstract]   [Full Text] [Related]  

  • 8. Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency.
    Chen HK; Chen CK; Tzeng NS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1615-6. PubMed ID: 18597910
    [No Abstract]   [Full Text] [Related]  

  • 9. Mania associated with initiation of ziprasidone.
    Nolan BP; Schulte JJ
    J Clin Psychiatry; 2003 Mar; 64(3):336. PubMed ID: 12716277
    [No Abstract]   [Full Text] [Related]  

  • 10. Ziprasidone hydrochloride.
    Am J Health Syst Pharm; 2002 Jan; 59(1):28-9. PubMed ID: 11813463
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged erections associated with ziprasidone treatment: a case report.
    Reeves RR; Kimble R
    J Clin Psychiatry; 2003 Jan; 64(1):97-8. PubMed ID: 12590634
    [No Abstract]   [Full Text] [Related]  

  • 12. Strategies for successful clinical management of schizophrenia with ziprasidone.
    Fagiolini A; Cañas F; Gallhofer B; Larmo I; Levy P; Montes JM; Papageorgiou G; Zink M; Rossi A
    Expert Opin Pharmacother; 2010 Sep; 11(13):2199-220. PubMed ID: 20658947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comments on the report of neuroleptic malignant syndrome induced by ziprasidone.
    Margetic B; Aukst-Margetic B
    World J Biol Psychiatry; 2007; 8(2):131-2; author reply 133-4. PubMed ID: 17455107
    [No Abstract]   [Full Text] [Related]  

  • 14. Switching among antipsychotics in everyday clinical practice: focus on ziprasidone.
    Rossi A; Cañas F; Fagiolini A; Larmo I; Levy P; Montes JM; Papageorgiou G; Sturlason R; Zink M; Correll CU
    Postgrad Med; 2011 Jan; 123(1):135-59. PubMed ID: 21293094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinsonism with intramuscular ziprasidone.
    Bilal L; Tsai C; Gasper JJ; Ndlela JC
    Am J Psychiatry; 2005 Dec; 162(12):2392-3. PubMed ID: 16330610
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study.
    Montejo AL; Rico-Villademoros F;
    J Clin Psychopharmacol; 2008 Oct; 28(5):568-70. PubMed ID: 18794656
    [No Abstract]   [Full Text] [Related]  

  • 17. Ziprasidone-induced acute dystonia.
    Mason MN; Johnson CE; Piasecki M
    Am J Psychiatry; 2005 Mar; 162(3):625-6. PubMed ID: 15741487
    [No Abstract]   [Full Text] [Related]  

  • 18. Priapism associated with two atypical antipsychotic agents.
    Reeves RR; Mack JE
    Pharmacotherapy; 2002 Aug; 22(8):1070-3. PubMed ID: 12173794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of switching from aripiprazole to ziprasidone in patients with schizophrenia.
    Kim SW; Shin IS; Kim JM; Bae KY; Yang SJ; Yoon JS
    Clin Neuropharmacol; 2010 May; 33(3):121-5. PubMed ID: 20502130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperosmolar hyperglycemic state associated with ziprasidone treatment: a case report.
    Létourneau G; Abdel-Baki A; Dubreucq S; Mahone M; Granger B
    J Clin Psychopharmacol; 2011 Oct; 31(5):671-3. PubMed ID: 21881458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.